Working…
Help guide our efforts to modernize ClinicalTrials.gov.
Send us your comments by March 14, 2020.
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 1 of 51 for:    DOTA- | Neuroendocrine Tumors
Previous Study | Return to List | Next Study

Yttrium-90 DOTA-TOC Intra-arterial (IA) Peptide Receptor Radionuclide Therapy (PRRT) for Neuroendocrine Tumor

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03197012
Recruitment Status : Active, not recruiting
First Posted : June 23, 2017
Last Update Posted : December 24, 2019
Sponsor:
Information provided by (Responsible Party):
Thomas Hope, University of California, San Francisco

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : October 30, 2020
Estimated Study Completion Date : October 30, 2020